BlackRock, Inc.

13F Holdings History for HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

Symbol: HALO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 12.6M shares
Security Ownership: 10.2%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in HALOZYME THERAPEUTICS, INC. Common Stock (HALO)

2025-07-17 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 12.6M shares of HALOZYME THERAPEUTICS, INC. Common Stock (HALO). This represents 10.2% percent ownership of the company. In their previous filing dated 2025-04-28, BlackRock, Inc. had reported owning 16.1M shares, indicating a decrease of -21.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BlackRock, Inc.	10.2%	-22.3%	$634M	12.6M	-3,531,864	-21.9%	$50.23	13G/A	6/30/2025	17 Jul 2025 19:54:40
BlackRock, Inc.	13.1%		$972M	16.1M			$60.22	13G/A	3/31/2025	28 Apr 2025 17:18:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.02%	0%	$943M	12.9M	-339,833	-2.57%	$73.34	Q3 2025
6/30/2025	0.01%	0%	$687M	13.2M	-3,892,079	-22.8%	$52.02	Q2 2025
3/31/2025	0.02%	0%	$1.09B	17.1M	-474,044		$63.81	Q1 2025
12/31/2024	0.02%	+0%	$840M	17.6M	+136,136	+0.78%	$47.81	Q4 2024
9/30/2024	0.02%		$998M	17.4M			$57.24	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.